- Market Capitalization, $K 152,173,904
- Shares Outstanding, K 2,624,593
- Annual Sales, $ 26,617 M
- Annual Income, $ 3,196 M
- 60-Month Beta 0.55
- Price/Sales 5.71
- Price/Cash Flow 18.05
- Price/Book 10.59
|Period||Period Low||Period High||Performance|
| || |
+1.57 (+2.74%)since 05/24/21
| || |
+10.25 (+21.02%)since 03/24/21
| || |
+6.91 (+13.26%)since 06/24/20
EU approves AstraZeneca's (AZN) rare disease drug, Koselugo and expanded use of J&J's (JNJ) Darzalex Faspro and Sanofi's (SNY) Aubagio.
AstraZeneca's (AZN) Koselugo becomes the first medicine approved in Europe for neurofibromatosis type 1 plexiform neurofibromas.
A court in Brussels orders AstraZeneca (AZN) to supply 80 million doses of its COVID-19 vaccine to Europe by Sep 27, 2021. The European Commission had requested for 300 million doses by end of September....
AstraZeneca's (AZN) phase III study on COVID-19 antibody cocktail fails to meet primary goal. Glaxo (GSK) signs a new co-development/commercialization deal for a cancer candidate with iTeos Therapeutics....
Astrazeneca (AZN) closed at $58.35 in the latest trading session, marking a -0.1% move from the prior day.
AstraZeneca's (AZN) antibody cocktail, AZD7442 fails to prevent people who were already infected from developing symptomatic COVID-19. However, it showed some efficacy in people who were not infected.
The Zacks Analyst Blog Highlights: Salesforce, Shopify, AstraZeneca, Micron and Ecolab
Top Research Reports for salesforce, Shopify & AstraZeneca
/PRNewswire/ -- The report has been added to offering.
/PRNewswire/ - The type 2 diabetes market is expected to grow by during 2021-2025, according to Technavio. The report offers a detailed analysis of the impact of the COVID-19 pandemic on the type 2 diabetes...
|Astrazeneca Plc ADR|
|Advisorshares Doubleline Value Equity ETF|
|Invesco Nasdaq Next Gen 100 ETF|
|Flexshares Intl Quality Div Fund|
|Pharmaceutical Vaneck ETF|
|GS Access Investment Grade Corp Bond|
|3rd Resistance Point||59.56|
|2nd Resistance Point||59.21|
|1st Resistance Point||58.59|
|1st Support Level||57.62|
|2nd Support Level||57.27|
|3rd Support Level||56.65|